Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China · Delayed Price · Currency is CNY 22.92
-0.30 (-1.29%)
Jul 30, 2026, 3:00 PM CST
SHA:603351 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,342 | 1,335 | 1,297 | 1,156 | 1,111 | 1,042 |
Revenue Growth | 1.90% | 2.95% | 12.19% | 4.04% | 6.59% | 41.60% |
Gross Profit Gross Profit Growth | 380.81 | 373.97 | 358.26 | 312.87 | 300.36 | 279.63 |
Operating Income Operating Income Growth | 180.72 | 176.89 | 169.27 | 132.2 | 117.04 | 122.46 |
Net Income Net Income Growth | 152.02 | 150.97 | 146.42 | 112.2 | 95.03 | 101.37 |
Earnings Per Share EPS Growth | 1.12 | 1.11 | 1.08 | 0.83 | 0.71 | 0.76 |
EPS Growth | 2.77% | 2.78% | 30.12% | 16.90% | -6.58% | -1.30% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Synthetic Lubricating Base Oil Synthetic Lubricating Base Oil Growth | 900.38 |
Medical Supplements Medical Supplements Growth | 349.64 |
Emulsifier Emulsifier Growth | 67.85 |
Others Others Growth | 17.16 |
Total Total Growth | 1,335 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 438.46 | 423.87 | 247.2 | 158.8 | 100.93 | 92.5 |
Total Debt Total Debt Growth | 591.52 | 574.67 | 481.25 | 486.96 | 426.06 | 199.89 |
Net Cash (Debt) Net Cash Growth | -153.06 | -150.81 | -234.05 | -328.16 | -325.13 | -107.39 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.13 | -1.11 | -1.73 | -2.43 | -2.43 | -0.81 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 233.23 | 238.24 | 221.79 | 120.24 | 108.99 | -11.54 |
Capital Expenditures CapEx Growth | -46.38 | -52.18 | -51.46 | -73.07 | -233.9 | -235.62 |
Free Cash Flow Free Cash Flow Growth | 186.85 | 186.07 | 170.34 | 47.17 | -124.91 | -247.16 |
Free Cash Flow Growth | 19.03% | 9.23% | 261.09% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 28.38% | 28.01% | 27.63% | 27.07% | 27.03% | 26.83% |
Operating Margin | 13.47% | 13.25% | 13.05% | 11.44% | 10.54% | 11.75% |
Pretax Margin | 12.94% | 12.93% | 13.27% | 10.51% | 10.16% | 11.39% |
Profit Margin | 11.33% | 11.31% | 11.29% | 9.71% | 8.55% | 9.73% |
FCF Margin | 13.93% | 13.94% | 13.14% | 4.08% | -11.24% | -23.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.600 | 0.600 | 0.400 | 0.300 | 0.280 | 0.300 |
Dividend Per Share Growth | 50.00% | 50.00% | 33.33% | 7.14% | -6.67% | 0% |
Dividend Yield | 2.58% | 2.36% | 1.69% | 1.20% | 1.38% | 0.83% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.73 | 23.34 | 22.72 | 31.83 | 30.84 | 50.49 |
P/FCF Ratio | 16.83 | 18.94 | 19.53 | 75.71 | - | - |
PS Ratio | 2.34 | 2.64 | 2.57 | 3.09 | 2.64 | 4.91 |